ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company, and several distinguished researchers will highlight advances in Next-Generation Protein Sequencing™ (NGPS™) at the US Human Proteome Organization’s 2025 conference in Philadelphia, Pennsylvania through a panel discussion and multiple poster presentations.

Sponsored Panel Discussion: Breaking Boundaries in Proteomics

Quantum-Si is sponsoring and moderating the panel event “Breaking Boundaries: How Next-Generation Protein Sequencing™ is Shaping the Future of Proteomics” on February 25 from 12:30-1:30 PM ET. The session will provide an overview of the latest research leveraging Quantum-Si’s Platinum® Pro benchtop instrument, including a pioneering protein barcoding kit for sample multiplexing and a new library preparation solution for lower sample input.

Following the presentation, Dr. Benjamin Garcia (Washington University in St. Louis), Dr. Stephanie Cologna (University of Illinois Chicago), and Dr. John Prensner (University of Michigan) will engage in a discussion on the transformative impact of NGPS on proteomics, its role in overcoming existing challenges, and its integration with complementary technologies.

Scientific Posters Highlighting NGPS Innovation

Protein Sequencing with Single Amino Acid Resolution Discerns Myopathy-linked Regions in Tropomyosin Peptidoforms

  • Presenter: Madison Mehlferber, Ph.D., Postdoctoral Research Associate, University of Virginia
  • Demonstrates the ability of NGPS to differentiate structurally similar tropomyosin isoforms and post-translational modifications, highlighting its potential for resolving protein complexity at the single-amino-acid level
  • February 24th, Poster 777

Reducing Protein Input for Next-Generation Protein Sequencing on the Platinum Instrument

  • Presenter: Madelyn Davis, Field Application Scientist, Quantum-Si
  • Introduces a new Library Prep Kit that significantly lowers the required protein input while maintaining high sequencing accuracy, expanding the applicability of NGPS to biological and clinical samples.
  • February 25th Poster 792

Accurate Measurement of Peptide Variant Mixtures with Next-Generation Protein Sequencing

  • Presenter: Deepak Mistry
  • Demonstrates a partitioning model that enhances the precision of peptide variant composition estimation, facilitating improved NGPS analysis in biological and synthetic peptide mixtures
  • February 25th Poster 794

Protein Barcoding and Next-Generation Protein Sequencing for Multiplexed Protein Selection, Analysis and Tracking

  • Presenter: Joel McDade, Ph.D.
  • Introduces protein barcoding as a transformative tool for the multiplexed identification and characterization of proteins, providing a robust mechanism for precise tracking of protein affinity, location, and expression
  • February 25th Poster 796

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® line of instruments enables Next-Gen Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.